Results 31 to 40 of about 51,598 (348)
Exploration of Neuroprotective Therapy, 2022 Stroke causes acute neurological deficit which is an important cause of morbidity and mortality. Neurorehabilitation is an important dimension in the management of post-stroke deficits. Spasticity, pain, and neurological deficits are contributors to post-
Nirmal Surya, Guhan Ramamurthy
doaj +1 more source
Impaired H-Reflex Adaptations Following Slope Walking in Individuals With Post-stroke Hemiparesis [PDF]
, 2019 Background and Purpose: Short term adaptations in the Ia afferent-motoneuron pathway, as measured using the H-reflex, in response to altered ground reaction forces (GRFs) applied at the feet during slope walking have been observed in the non-impaired ...
Akoopie, Eric +5 more
core +2 more sources
Impaired muscle growth in spastic cerebral palsy [PDF]
Developmental Medicine & Child Neurology, 2013 This commentary is on the original article by Smith et al on pages 264–270 of this issue.
Barrett, Rod S, Barber, Lee
openaire +3 more sources
Cycle-to-cycle control of swing phase of paraplegic gait induced by surface electrical stimulation [PDF]
, 1995 Parameterised swing phase of gait in paraplegics was obtained using surface electrical stimulation of the hip flexors, hamstrings and quadriceps; the hip flexors were stimulated to obtain a desired hip angle range, the hamstrings to provide foot ...
Baardman, G. +4 more
core +3 more sources
Cost minimization analysis of BoNT-As in the treatment of upper limb spasticity and cervical dystonia [PDF]
, 2016 Botulinum toxin type A (BoNT-A) injections are recommended for the management of upper limb spasticity (ULS) and cervical dystonia (CD). The main aim of this cost minimization analysis (CMA) was to compare the annual cost per patient for three BoNT-As ...
Bartolomei, Luigi +15 more
core +1 more source
Associations between muscle morphology and spasticity in children with spastic cerebral palsy
European Journal of Paediatric Neurology, 2023 Due to the heterogeneous clinical presentation of spastic cerebral palsy (SCP), which makes spasticity treatment challenging, more insight into the complex interaction between spasticity and altered muscle morphology is warranted.We studied associations between spasticity and muscle morphology and compared muscle morphology between commonly observed ...
Peeters, Nicole +9 more
openaire +4 more sources
The correlation between lower limb spasticity and proprioceptive dysfunction in post-stroke patients
Frontiers in NeurologyObjectiveTo investigate the correlation between lower limb spasticity and proprioception in stroke patients, to analyze the influencing factors of spasticity, and to evaluate the predictive value of musculoskeletal ultrasound parameters on spasticity ...
Shiai Gao, Zifu Yu, Xihua Liu
doaj +1 more source
Scientific Reports, 2022 Hemiparesis and spasticity are common co-occurring manifestations of hemispheric stroke. The relationship between impaired precision and force in voluntary movement (hemiparesis) and the increment in muscle tone that stems from dysregulated activity of ...
Silvi Frenkel-Toledo +7 more
doaj +1 more source
Toxins, 2021 Botulinum toxin type A (BoNT-A) represents a first-line treatment for spasticity, a common disabling consequence of many neurological diseases. Electrical stimulation of motor nerve endings has been reported to boost the effect of BoNT-A. To date, a wide
Alessandro Picelli +6 more
doaj +1 more source
SPG10 is a rare cause of spastic paraplegia in European families [PDF]
, 2008 Background: SPG10 is an autosomal dominant form of hereditary spastic paraplegia (HSP), which is caused by mutations in the neural kinesin heavy chain KIF5A gene, the neuronal motor of fast anterograde axonal transport.
Auer-Grumbach, M. +10 more
core +2 more sources